fda warning letters to compounding pharmacies bpc-157 Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling This is the first vote

Therapy with the BPC-157 peptide not only creates a "barrier" that acts protectively and prophylactically to shield the heart and improve its function but also reduces undesirable processes related to heart dysfunction

I've been using some single dose ampules which expired 2/2022, they seem fine, based on my symptoms

The observed decrease in serum ferritin concentration might have been secondary to depletion of the bodys iron reserves after bariatric surgery as the prevalence of anemia in the Optimum 2.0 group increased from 13% at T24 to 18% at T36, suggesting that the bodys iron stores were not sufficient to prevent patients from developing iron-deficiency anemia

Note: Because AOD-9604 does not affect glucose metabolism or IGF-1, monitoring requirements are simpler than with growth hormone therapy

Its also sourced from extrapolated animal research

If you are experiencing a medical emergency, call 911 or seek immediate medical attention